Skip to content

Epidemiological Study on the Management of Out-of-hospital Cardiac Arrest Survivors in Champagne ArDEnnes

Epidemiological Study on the Management of Out-of-hospital Cardiac Arrest Survivors in Champagne ArDEnnes

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04993716
Acronym
CASCADE
Enrollment
294
Registered
2021-08-06
Start date
2021-10-04
Completion date
2023-12-31
Last updated
2022-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Out-of-hospital Cardiac Arrest

Brief summary

Out-of-hospital cardiac arrest (OHCA) is a public health problem, affecting 50,000 people per year in France. Intervention time (initiation of cardiopulmonary resuscitation (CPR) and advanced CPR) are associated with a better prognosis. Despite this, the latest published data show a very low overall survival (5%). Our territory has only three centers distributed hospitals with both a 24-hour coronary angiography platform and an intensive care unit. Finally, although 60% of ACEHs receive coronary angiography in the Île de France region, it is performed on only 15% of patients in the Reims University Hospital. Therefore, it seems essential to conduct a study on the reality of the support of ACEH and to study the clinical and biological factors as well as the influence of the geographical distribution of specialized technical platforms on the prognosis of patients.

Interventions

OTHERobservational

Collect from a bank of biological samples, identification of prognostic factors associated with survival without serious neurological heavy sequelae

Sponsors

Stephane Sanchez
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient victim of ACEH in the Champagne-Ardenne region admitted living in hospital.

Exclusion criteria

* patient under the age of 18

Design outcomes

Primary

MeasureTime frame
Analysis of prognostic factors associated with survival without severe neurological sequelae (CPC 1-2) at 3 months among the following variables3 months
Analysis of prognostic factors associated with survival without severe neurological sequelae (CPC 1-2) with collection of a bank of biological samples, identification of clinical factors and targeted temperature control12 months

Countries

France

Contacts

Primary ContactStéphane Sanchez, MD
stephane.sanchez@hcs-sante.fr+33625036892

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026